Answers are grounded in this paper and cite their sources.
We (Angelotti et al., 2012; Romagnani et al., 2013; Ronconi et al., 2009; Sagrinati et al., 2006) and others (Lindgren et al., 2011; Sallustio et al., 2013) previously demonstrated that in fresh renal tissue, adult human kidneys contain a population of renal stem and more committed progenitor cells characterized by co-expression of surface markers CD133 and CD24. These cells can be expanded in culture while maintaining their phenotype, and they exhibit self-renewal potential as well as the capacity to differentiate into podocytes and tubular cells both in vitro and in vivo (Angelotti et al., 2012; Lindgren et al., 2011; Romagnani et al., 2013; Ronconi et al., 2009; Sagrinati et al., 2006; Sallustio et al., 2013). Consistently, CD133+ renal cells represent a subset of CD24+ cells during human kidney development, when they constitute the metanephric mesenchyme-derived primordial nephron (Lazzeri et al., 2007). In their manuscript published in the August issue of Stem Cell Research, Bombelli et al. describe the isolation of putative novel renal stem cells by culturing nephrosphere suspensions from adult human kidneys (Bombelli et al., 2013). Based on our previous studies,
No takes yet. Share an insight, caveat, or question.
Romagnani et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: